Pashto Translation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Sep 17, 2021
Trial Information
Current as of April 25, 2025
Completed
Keywords
ClinConnect Summary
The Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) pain scale, a screening questionnaire for identifying patients with neuropathic pain, was developed to identify patients with neuropathic mechanisms dominating their pain experience. The original English version of the LANSS pain scale has been translated and validated in Turkish, Spanish, Swedish, Brazilian, Portuguese, and Chinese Mandarin languages. However, no neuropathic pain questionnaire including the LANSS has yet been established in Pasto language in Pakistan.
Although these screening tools are based on descriptors, th...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients with traumatic spinal cord injury
- • Both Complete and Incomplete SCI patients
- • Patients having pain history after spinal cord injury
- • Patients having 3 or more than 3 months duration of SCI
- • SCI at or below thoracic spine
- Exclusion Criteria:
- • Patients with other neurological disorders like multiple sclerosis, GBS, etc.
- • Congenital conditions, tumor etc.
- • Diabetic patients.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Peshawar, Kpk, Pakistan
Patients applied
Trial Officials
Mirza Obaid Baig, MSPT(NMR)
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials